Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-10-18
2000-11-28
Carlson, Karen Cochrane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 13, 530324, 530325, 530326, 530350, 4241841, 4241851, 4241891, 4242251, A61K 3816, C07K 1418
Patent
active
061535796
ABSTRACT:
The present invention relates to compositions and crystals of a hepatitis C virus protease in complex with its viral cofactor. This invention also relates to methods of using the structure coordinates of hepatitis C virus protease in complex with a synthetic NS4A to solve the structure of similar or homologous proteins or protein complexes.
REFERENCES:
patent: 4833233 (1989-05-01), Carter
patent: 5353236 (1994-10-01), Subbiah
Satoh et al. `The N-Terminal Region of Hepatitis C Virus Nonstructural Protein 3(NS3) is Essential for Stable Complex Formation with NS4A`, J. of Virology. vol. 69, No. 7, pp. 4255-4260, Jul. 1995.
P.N. Bryan, "Protein Engineering", Biotech Adv., 5, pp. 221-234 (1987).
I.D. Campbell et al., "Diffraction, in Biological Spectroscopy", The Benjamin/Cummings Publishing Company, Inc., Menlo Park, CA, pp. 299-326 (1984).
J. Jancarik et al., "Sparse Matrix Sampling: A Screening Method for Crystallization of Proteins", J. Appl. Cryst., 24, pp. 409-411 (1991).
A. Kajihara et al., "Protein Modelling Using a Chimera Reference Protein Derived From Exons", Protein Eng'g, 6, pp. 615-620 (1993).
D. Musil et al., "The Refined 2.15 .ANG. X-Ray Crystal Structure of Human Liver Cathepsin B: the Structural Basis for its Specificity", EMBO J., 10(9), pp. 2321-2330 (1991).
A.J. Russell et al., "Rational Modification of Enzyme Catalysis by Engineering Surface Charge", Nature, 328, pp. 496-500 (1987).
A.R. Sielecki et al., "Structure of Recombinant Human Renin, a Target for Cardiovascular-Active Drugs, at 2.5 .ANG. Resolution", Science, 243, pp. 1346-1351 (1989).
Y. Tanji et al., "Hepatitis C Virus-Encoded Nonstructural Protein NS4A Has Versatile Functions in Viral Protein Processing", J. Virology, 69(3), pp. 1575-1581 (Mar. 1995).
Y. Shimizu et al., "Identification of the Sequence of NS4A Required for Enhanced Cleavage of the NS5A/5B Site by Hepatitis C Virus NS3 Protease", J. Virology, 70(1), pp. 127-132 (Jan. 1996).
U. Uhlin et al., "Crystallization and Crystallographic Investigations of Ribonucleotide Reductase Protein R1 From Escherichia Coli", FEBS, 336(1), pp. 148-152 (1993).
C.S. Wright et al., "Structure of Subtilisin BPN'at 2.5 .ANG. Resolution", Nature, 221, pp. 235-242 (1969).
Fox Ted
Kim Joseph L.
Lin Chao
Morgenstern Kurt A.
Thomson John A.
Carlson Karen Cochrane
Dixon Lisa A.
Gupta Anish
Haley, Jr. Esq. James F.
Vertex Pharmaceuticals Incorporated
LandOfFree
Crystallizable compositions comprising a hepatitis C virus NS3 p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystallizable compositions comprising a hepatitis C virus NS3 p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystallizable compositions comprising a hepatitis C virus NS3 p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1725889